← Back to Search

Co-Scheduled Newborn and Contraception Care for Postpartum Women (LINCC Trial)

N/A
Waitlist Available
Led By Sadia Haider, MD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

LINCC Trial Summary

This trial will improve access to timely contraception for women who deliver babies, by developing and implementing a new approach to connect contraception care with newborn care.

Who is the study for?
This trial is for women who have recently given birth and are visiting one of the selected 7 CHC sites with their infants for the first well-baby visit, typically 3-5 days post-delivery. It's not open to men, or women who had tubal ligation or planned long-term birth control right after delivery, nor those who needed an emergency hysterectomy.Check my eligibility
What is being tested?
The study is testing a new approach called LINCC intervention that links postpartum contraception care with newborn baby care by scheduling them together. The goal is to improve access to timely postpartum contraception and reduce health risks associated with pregnancies occurring close together.See study design
What are the potential side effects?
Since this trial focuses on scheduling interventions rather than medications or medical procedures, there are no direct side effects related to drugs or treatments. However, participants may experience logistical issues or stress related to attending combined appointments.

LINCC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients who receive contraception by two months postpartum
Secondary outcome measures
Number of patients who present with a short inter-pregnancy interval pregnancies
Number of patients who receive contraception by six months postpartum

LINCC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Aim 2Experimental Treatment1 Intervention
During the intervention period, staff will capture women during the first well-baby visit (WBV) and offer to have the next visit co-scheduled for infant and contraception care. Appointments are scheduled during the discharge process at the end of each WBV. During the discharge process all women 0-6 months postpartum will be identified by clerical staff through review of each pediatric clinic beforehand and through an electronic flag alert in the infant's electronic medical record. The pre-review of pediatric clinic schedules and the use of the flag will remind staff to offer the mother a co-scheduled visit for newborn and contraceptive care at the time of the next newborn visit.
Group II: Control - Aim 2Active Control1 Intervention
Clinics will schedule postpartum contraception using normal clinic procedures.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
160,864 Total Patients Enrolled
AllianceChicagoOTHER
6 Previous Clinical Trials
14,514 Total Patients Enrolled
University of Illinois at ChicagoOTHER
607 Previous Clinical Trials
1,556,688 Total Patients Enrolled

Media Library

LINCC intervention - enable co-schedule feature Clinical Trial Eligibility Overview. Trial Name: NCT04092530 — N/A
Family Planning Research Study Groups: Control - Aim 2, Intervention - Aim 2
Family Planning Clinical Trial 2023: LINCC intervention - enable co-schedule feature Highlights & Side Effects. Trial Name: NCT04092530 — N/A
LINCC intervention - enable co-schedule feature 2023 Treatment Timeline for Medical Study. Trial Name: NCT04092530 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to enlist in this medical research?

"This clinical trial is seeking 1198 patients, all of whom must have family planning in place and must be between 18 to 45 years old."

Answered by AI

Is this research project currently recruiting participants?

"According to the clinicaltrials.gov website, this medical experiment is currently recruiting participants with its initial posting on April 1st 2021 and most recent update occurring November 18th 2022."

Answered by AI

Could individuals aged 85 or younger be considered for this analysis?

"The lower age limit for this clinical trial is 18, while the upper threshold of 45 years old must not be exceeded."

Answered by AI

What is the upper-limit of participants enrolled in this research?

"This study requires 1198 participants who meet the necessary prerequisites. Friend Health in Chicago, Illinois and Settlement Health in New york, New York are two of many locations offering this trial to potential patients."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
How old are they?
18 - 65
What site did they apply to?
Heartland Health Centers
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Linking Inter-professional Newborn and Contraception Care
2021. "Linking Inter-professional Newborn and Contraception Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04092530.
~70 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top